Brief: BioSyent Inc QTRLY EPS C$0.14
13/03/2025 21:46
March 13 (Reuters) - Biosyent Inc RX.V: BIOSYENT INC QTRLY EPS C$0.14 Source text: ID:nGNX9m5HPn Further company coverage: RX.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid